# David A. Bushinsky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-a-bushinsky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,134 |
| Field | Parathyroid Disorders and Treatments |
| h-index | 70 |
| i10-index | 199 |
| Last Known Institution | University of Rochester |
| OpenAlex ID | https://openalex.org/A5091483213 |
| ORCID iD | 0000-0002-4030-2922 |
| Works | 339 |

## Researcher papers

- [Hospital-acquired renal insufficiency: A prospective study](https://scholariq.org/papers/hospital-acquired-renal-insufficiency-a-prospective-study/)
- [Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors](https://scholariq.org/papers/patiromer-in-patients-with-kidney-disease-and-hyperkalemia-receiving-raas/)
- [Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial](https://scholariq.org/papers/evaluation-of-the-efficacy-and-safety-of-rly5016-a-polymeric-potassium-binder-in/)
- [Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease](https://scholariq.org/papers/effect-of-patiromer-on-serum-potassium-level-in-patients-with-hyperkalemia-and/)
- [Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease](https://scholariq.org/papers/sustained-long-term-renal-stabilization-after-54-months-of-agalsidase-therapy-in/)
- [Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes](https://scholariq.org/papers/association-of-serum-potassium-with-all-cause-mortality-in-patients-with-and/)
- [Calcium](https://scholariq.org/papers/calcium/)
- [Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism](https://scholariq.org/papers/effect-of-etelcalcetide-vs-cinacalcet-on-serum-parathyroid-hormone-in-patients/)
- [Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro](https://scholariq.org/papers/acidosis-inhibits-osteoblastic-and-stimulates-osteoclastic-activity-in-vitro/)
- [Bone buffering of acid and base in humans](https://scholariq.org/papers/bone-buffering-of-acid-and-base-in-humans/)
- [Effect of Patiromer on Reducing Serum Potassium and Preventing Recurrent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease on Raas Inhibitors](https://scholariq.org/papers/effect-of-patiromer-on-reducing-serum-potassium-and-preventing-recurrent/)
- [Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors](https://scholariq.org/papers/effect-of-patiromer-on-hyperkalemia-recurrence-in-older-chronic-kidney-disease/)

## Researcher topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Renal function and acid-base balance](https://scholariq.org/topics/renal-function-and-acid-base-balance/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Magnesium in Health and Disease](https://scholariq.org/topics/magnesium-in-health-and-disease/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Researcher university

- [University of Rochester](https://scholariq.org/institutions/university-of-rochester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.